Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative
Journal of Vascular Surgery · 2023-09 · 78 (3) · 745-753.e6
DOI: 10.1016/j.jvs.2023.05.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2023-09. Verfasst von Jacob Cleman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Medicine Outcomes Program, Yale University, New Haven, CT. Hauptthemen laut MEDLINE: Endovascular Procedures, Peripheral Arterial Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
OBJECTIVE: There is a relative lack of comparative effectiveness research on revascularization for patients with chronic limb-threatening ischemia (CLTI). We examined the association between lower extremity bypass (LEB) vs peripheral vascular intervention (PVI) for CLTI and 30-day and 5-year all-cause mortality and 30-day and 5-year amputation. METHODS: Patients undergoing LEB and PVI of the below-the-knee popliteal and infrapopliteal arteries between 2014 and 2019 were queried from the Vascular Quality Initiative, and outcomes data were obtained from the Medicare claims-linked Vascular Implant Surveillance and Interventional Outcomes Network database. Propensity scores were calculated on 15 variables using a logistic regression model to control for imbalances between treatment groups. A 1:1 matching method was used. Kaplan-Meier survival curves and hierarchical Cox proportional hazards regression with a random intercept for site and operator nested in site to account for clustered data compared 30-day and 5-year all-cause mortality between groups. Thirty-day and 5-year amputation were subsequently compared using competing risk analysis to account for the competing risk of death. RESULTS: There was a total of 2075 patients in each group. The overall mean age was 71 ± 11 years, 69% were male, and 76% were white, 18% were black, and 6% were of Hispanic ethnicity. Baseline clinical and demographic characteristics in the matched cohort were balanced between groups. There was no association between all-cause mortality over 30 days and LEB vs PVI (cumulative incidence, 2.3% vs 2.3% by Kaplan Meier; log-rank P-value = .906; hazard ratio [HR], 0.95; 95% confidence interval [CI], 0.62-1.44; P-value = .80). All-cause mortality over 5 years was lower for LEB vs PVI (cumulative incidence, 55.9% vs 60.1% by Kaplan Meier; log-rank P-value < .001; HR, 0.77; 95% CI, 0.70-0.86; P-value < .001). Accounting for competing risk of death, amputation over 30 days was also lower in LEB vs PVI (cumulative incidence function, 1.9% vs 3.0%; Fine and Gray P-value = .025; subHR, 0.63; 95% CI, 0.42-0.95; P-value = .025). There was no association between amputation over 5 years and LEB vs PVI (cumulative incidence function, 22.6% vs 23.4%; Fine and Gray P-value = .184; subHR, 0.91; 95% CI, 0.79-1.05; P-value = .184). CONCLUSIONS: In the Vascular Quality Initiative-linked Medicare registry, LEB vs PVI for CLTI was associated with a lower risk of 30-day amputation and 5-year all-cause mortality. These results will serve as a foundation to validate recently published randomized controlled trial data, and to broaden the comparative effectiveness evidence base for CLTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vascular Medicine Outcomes Program, Yale University, New Haven, CT.
- Division of Vascular Surgery, Yale School of Medicine, New Haven, CT.
- Vascular Medicine Outcomes Program, Yale University, New Haven, CT; Department of Psychiatry, Yale School of Medicine, New Haven, CT.
- Vascular Medicine Outcomes Program, Yale University, New Haven, CT. Electronic address: carlos.menahurtado@yale.edu.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Cleman, J., Romain, G., Grubman, S., Guzman, R. J., Smolderen, K. G., & Mena-Hurtado, C. (2023). Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative. Journal of Vascular Surgery, 78(3), 745-753.e6. https://doi.org/10.1016/j.jvs.2023.05.015
Vancouver
Cleman J, Romain G, Grubman S, Guzman RJ, Smolderen KG, Mena-Hurtado C. Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative. Journal of Vascular Surgery. 2023;78(3):745-753.e6. doi:10.1016/j.jvs.2023.05.015
BibTeX
@article{Cleman2023,
author = {Cleman, Jacob and Romain, Gaëlle and Grubman, Scott and Guzman, Raul J and Smolderen, Kim G and Mena-Hurtado, Carlos},
title = {Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative},
journal = {Journal of Vascular Surgery},
year = {2023},
volume = {78},
number = {3},
pages = {745--753.e6},
doi = {10.1016/j.jvs.2023.05.015}
}
EUVIMED